Leadership & Pay ·
Gain Therapeutics appoints Jeanette Weidner as VP Finance and CFO effective Oct 28
GANXGain Therapeutics, Inc.
Gain Therapeutics appointed Jeanette Weidner as Vice President of Finance, Chief Financial Officer, and Principal Accounting Officer, effective October 28, 2026. Ms. Weidner brings over 18 years of accounting and finance experience in the life sciences sector, including prior roles at Senseonics Holdings and OncoC4. Her employment agreement includes a $275,000 annual base salary, a target incentive bonus of 35% of base pay, and an initial stock option grant for 130,000 shares vesting over four years. The company operates in the biopharmaceutical industry, focusing on the discovery and development of novel therapeutics.